Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.

πŸ‡¨πŸ‡³China
Ownership
-
Employees
-
Market Cap
-
Website

Extension Study of ABP-671 in Participants With Gout

Phase 2
Conditions
Interventions
First Posted Date
2024-02-26
Last Posted Date
2024-08-15
Lead Sponsor
Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
Target Recruit Count
580
Registration Number
NCT06276556
Locations
πŸ‡ΊπŸ‡Έ

Tucson Neuroscience Research, LLC, Tucson, Arizona, United States

πŸ‡ΊπŸ‡Έ

New Horizons Research, Palmetto Bay, Florida, United States

πŸ‡ΊπŸ‡Έ

DelRicht Research of Gulfport, Gulfport, Mississippi, United States

and more 51 locations

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers

Phase 1
Recruiting
Conditions
Interventions
First Posted Date
2024-02-14
Last Posted Date
2024-02-14
Lead Sponsor
Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
Target Recruit Count
126
Registration Number
NCT06258213
Locations
πŸ‡ΊπŸ‡Έ

Worldwide Clinical Trials, San Antonio, Texas, United States

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

Phase 2
Active, not recruiting
Conditions
Interventions
First Posted Date
2023-04-18
Last Posted Date
2024-08-15
Lead Sponsor
Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
Target Recruit Count
580
Registration Number
NCT05818085
Locations
πŸ‡ΊπŸ‡Έ

Annapolis Internal Medicine/CCT Research, Annapolis, Maryland, United States

πŸ‡ΊπŸ‡Έ

Bioclinical Research Alliance, Miami, Florida, United States

πŸ‡ΊπŸ‡Έ

A & D Doctor Center, Miami, Florida, United States

and more 51 locations

A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia

Phase 2
Completed
Conditions
Interventions
First Posted Date
2020-11-20
Last Posted Date
2023-04-12
Lead Sponsor
Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
Target Recruit Count
60
Registration Number
NCT04638543
Locations
πŸ‡¦πŸ‡Ί

Paratus - Central Coast Clinic, Kanwal, Australia

πŸ‡¦πŸ‡Ί

Paratus - Western Sydney Clinic, Sydney, Australia

πŸ‡¦πŸ‡Ί

Peninsula Private Hospital, Kippa-Ring, Australia

and more 2 locations

Study to Investigate the Effects of Food on Relative Bioavailability of ABP-671 Tablets in Healthy Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2020-03-10
Last Posted Date
2020-06-23
Lead Sponsor
Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
Target Recruit Count
12
Registration Number
NCT04303039
Locations
πŸ‡ΊπŸ‡Έ

Pharmaron CPC, Inc., Baltimore, Maryland, United States

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671

Phase 1
Completed
Conditions
Interventions
First Posted Date
2019-08-19
Last Posted Date
2020-02-12
Lead Sponsor
Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
Target Recruit Count
27
Registration Number
NCT04060173
Locations
πŸ‡ΊπŸ‡Έ

Celerion, Tempe, Arizona, United States

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2019-04-08
Last Posted Date
2020-07-29
Lead Sponsor
Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
Target Recruit Count
32
Registration Number
NCT03906006
Locations
πŸ‡ΊπŸ‡Έ

Celerion, Tempe, Arizona, United States

Β© Copyright 2024. All Rights Reserved by MedPath